| Action Summary | In June 2021, the federal Drug Enforcement Administration (DEA) published a final rule permitting DEA registrants who are authorized to dispense methadone for opioid use disorder to add a “mobile component” to their existing registrations. The Department of Behavioral Health and Developmental Services (DBDHS) is integrating these federal regulations into the Licensing Regulations due to provider interest in supplying these mobile medication assisted treatment (mobile MAT) services. The integration of the federal rules within the Licensing Regulations shall increase transparency and set administrative expectations for this service. The availability of mobile MAT is expected to help address the opioid crisis in Virginia. |
| Chapters Affected | Only affects this chapter. |
| Executive Branch Review | This action will go through the normal Executive Branch Review process. |
| RIS Project | Yes [7415] |
|
Is Federal action a driving factor in this regulatory change? If so, please provide a specific reference to the law, regulation
or court case.
21 CFR Parts 1300, 1301, and 1304
|
|
| New Periodic Review | This action will not be used to conduct a new periodic review. |
| Name / Title: | Susan H. Puglisi / Regulatory Research Specialist |
| Address: |
DBHDS Office of Regulatory Affairs 1220 Bank Street, 4th Floor South Richmond, VA 23219 |
| Email Address: | susan.puglisi@dbhds.virginia.gov |
| Phone: | (804)371-8043 FAX: (804)371-4609 TDD: (804)371-8977 |